Vivani Medical grants CEO 200K options, 100K RSUs

Vivani Medical, Inc. granted Chief Executive Officer Adam Mendelsohn 200,000 stock options and 100,000 performance-based RSUs on July 28, 2026.

Rhea-AI Filing Summary

Vivani Medical, Inc. granted Chief Executive Officer Adam Mendelsohn 200,000 stock options and 100,000 performance-based RSUs on July 28, 2026. The options have a $1.31 exercise price, a 10-year term, and vest 25% after one year then monthly for 36 months. Each RSU equals one share and vests in three stages tied to Vivani's stock trading at or above $3.15 for three consecutive trading days, with additional tranches one and two years after that date; the RSUs expire if this price condition is not met within four years and all vesting requires continued service.

Insider Trade Summary

Grant/Award: 300,000 shares

Grant/Award 2 txns

Insider Mendelsohn Adam

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock Option F1	200,000	$0.00	$0.00
Grant/Award	RSUs F2, F3	100,000	$0.00	$0.00

Holdings After Transaction: Common Stock Option — 200,000 contracts (Direct); RSUs — 100,000 contracts (Direct)

Footnotes (3)

1. F1. The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
2. F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.
3. F3. The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

Key Figures

Stock options granted: 200,000 shares Option exercise price: $1.31 per share Option term: 10 years +2 more

5 metrics

Stock options granted 200,000 shares Common Stock Options granted to CEO on 2026-07-28

Option exercise price $1.31 per share Exercise price for 200,000 stock options

Option term 10 years Term of CEO stock options expiring 2036-07-27

RSUs granted 100,000 units Performance-based restricted stock units granted to CEO

RSU price hurdle $3.15 per share Stock-price condition for RSU vesting over three trading days

Key Terms

restricted stock unit ("RSU"), performance based RSUs, contingent right to receive one share, vesting date

4 terms

restricted stock unit ("RSU") financial

"Each restricted stock unit ("RSU") represents a contingent right"

performance based RSUs financial

"The performance based RSUs shall vest in three stages"

contingent right to receive one share financial

"represents a contingent right to receive one share of Vivani common stock"

vesting date financial

"subject to continued service through each applicable vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Vivani Medical (VANI) grant to CEO Adam Mendelsohn?

Vivani Medical granted CEO Adam Mendelsohn 200,000 stock options and 100,000 performance-based RSUs on July 28, 2026. The options have a $1.31 exercise price, and both awards involve multi-year vesting tied to service and, for RSUs, share-price performance.

What are the key terms of Adam Mendelsohn's 200,000 Vivani (VANI) stock options?

The grant covers 200,000 Vivani common stock options with a $1.31 exercise price and a 10-year term, expiring July 27, 2036. Vesting is 25% after one year of service, then monthly vesting over the following 36 months, subject to continued employment.

How do the 100,000 performance-based RSUs for Vivani (VANI) CEO vest?

The 100,000 RSUs vest in three equal stages. One-third vests when Vivani's stock trades at or above $3.15 for three consecutive trading days, the next third one year later, and the final third one year after that, all requiring continued service.

What stock-price hurdle applies to Vivani (VANI) CEO Adam Mendelsohn's RSUs?

The performance condition requires Vivani's stock to be at or above $3.15 for three consecutive trading days within four years of the grant. If this hurdle is not met in that period, the 100,000 RSUs expire without vesting.

Does Adam Mendelsohn's latest Vivani (VANI) Form 4 report any stock sales?

No stock sales are reported. The Form 4 shows only acquisitions via compensation awards: 200,000 stock options and 100,000 performance-based RSUs, both granted at a $0.00 transaction price per unit, subject to vesting conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/30/2026 - 08:25 PM Accepted by SEC EDGAR 07/30/2026 - 08:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mendelsohn Adam

(Last) (First) (Middle)

C/O VIVANI MEDICAL, INC.

1350 S. LOOP ROAD

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Option	$1.31	07/28/2026		A		200,000		(1)	07/27/2036(1)	Common Stock	200,000	$0	200,000	D
RSUs	(2)	07/28/2026		A		100,000		(3)	(3)	Common Stock	100,000	$0	100,000	D

Explanation of Responses:

1. The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.

2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.

3. The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Adam Mendelsohn	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)